Tests categories

A cosmóve study performed using microarrays identifies unbalanced chromosomal changes in the genome as the genetic cause of pregnancy loss before 22 weeks.

The second step in the genetic diagnosis of medullary thyroid cancer is genetic testing, which involves detecting certain changes in the genetic material (DNA), namely mutations in the RET gene, whichóre likely to affect the development of the genetic disease, a hereditary form of thyroid cancer

Genetic testing detects a variant of the F13A1 gene, whichóry contains instructions for producing one part of a protein called coagulation factor XIII. The V34L sequence variant is a factor in preventing pulmonary embolism, deep vein thrombosis and myocardial infarction.

The test involves the determination in the blood of a compound called tissue-specific polypeptide (TPS), and it is used in the diagnosis and monitoring of the course of some cancersóalthough it can be detected in other conditions, such as pregnancy.

The test measures in a 24-hour collectionóurine levels of vanillin-malic acid (VMA), important for the diagnosis of pheochromocytoma tumors.

A urine test that measures cobalt levels, used to assess heavy metal exposure, for example, in people with cobalt-containing endoprostheses due to endoprosthesis wear.

A urine test that measures the level of tróichloroacetic acid, used in assessing exposure to chemicals.

The urine test measures the level of mianserin and is used in monitoring therapy and in cases of suspected poisoning with this drug.

A urine test to measure copper levels, important in diagnosing Wilson's disease.